ACOX2 is the human peroxisomal branched-chain acyl-CoA oxidase (EC 1.3.3.6), a FAD-dependent flavoenzyme of the acyl-CoA oxidase family. It catalyzes the first, oxygen-dependent and rate-limiting dehydrogenation step of peroxisomal beta-oxidation, removing two hydrogens and introducing a trans-2,3 double bond into the acyl-CoA substrate while generating hydrogen peroxide as a byproduct. Its principal physiological substrates are the C27 bile-acid intermediates (25S)-3alpha,7alpha,12alpha-trihydroxy- cholestanoyl-CoA (THCA-CoA) and dihydroxycholestanoyl-CoA (DHCA-CoA); ACOX2 initiates the side-chain shortening that converts these C27 cholestanoic acids into the mature C24 bile acids (cholic and chenodeoxycholic acid). It also oxidizes 2-methyl-branched-chain fatty acyl-CoA esters such as (2S)-pristanoyl-CoA (with redundancy to ACOX3) and monomethyl branched-chain fatty acids, acting stereospecifically on (2S)-methyl isomers, and can oxidize straight-chain acyl-CoAs with low efficiency. ACOX2 is a homodimer that resides in the peroxisomal matrix, imported via its C-terminal SKL (PTS1) targeting signal. It is expressed in many tissues, most abundantly in liver, kidney and heart. Loss-of-function causes ACOX2 deficiency (congenital bile acid synthesis defect 6, CBAS6), an autosomal recessive disorder marked by accumulation of toxic C27 bile-acid intermediates, persistent hypertransaminasemia and liver fibrosis, with variable neurological features.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005504
fatty acid binding
|
IBA
GO_REF:0000033 |
MARK AS OVER ANNOTATED |
Summary: Fatty acid binding propagated by phylogenetic inference. Substrate binding is implicit in the acyl-CoA oxidase catalytic mechanism, but a bare "fatty acid binding" molecular function term is uninformative for this enzyme, whose informative MF is its acyl-CoA oxidase (dehydrogenase) activity. Retained but flagged as an over-annotation.
Reason: ACOX2 acts on acyl-CoA thioesters (branched-chain and C27 bile-acid CoA esters), not on free fatty acids, and its informative molecular function is captured by the acyl-CoA oxidase activity terms. A generic "fatty acid binding" adds little functional information and is more precisely represented by the catalytic MF terms.
Propagation Review
Root cause:
TERM SCOPING PROBLEM
Failure modes:
GRANULARITY MISMATCH
ROLE CONFLATION
Sources checked:
PANTHER:PTN000097533
SUPPORTS SOURCE BUT NOT TARGET
Family-level "fatty acid binding" propagated from the acyl-CoA oxidase clade; ACOX2 acts on acyl-CoA thioesters, and the informative MF is its acyl-CoA oxidase activity.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Involved in peroxisomal beta-oxidation of branched-chain fatty acids (BCFAs) and bile acids intermediates.
|
|
GO:0033540
fatty acid beta-oxidation using acyl-CoA oxidase
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred involvement in fatty acid beta-oxidation via an acyl-CoA oxidase. This is exactly the pathway ACOX2 participates in, catalyzing the first oxidase step of peroxisomal beta-oxidation of branched-chain and bile-acid CoA esters.
Reason: Directly supported by experimental data (IDA/IMP from PMID:27884763) and by the UniProt PATHWAY assignment to peroxisomal fatty acid beta-oxidation. The IBA is at an appropriate level of specificity for an acyl-CoA-oxidase family enzyme.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Lipid metabolism; peroxisomal fatty acid beta-oxidation.
|
|
GO:0120524
long-chain fatty acyl-CoA oxidase activity
|
IBA
GO_REF:0000033 |
MARK AS OVER ANNOTATED |
Summary: Long-chain acyl-CoA oxidase activity inferred phylogenetically. ACOX2 can oxidize straight-chain long-chain acyl-CoAs (e.g. hexadecanoyl-CoA/C16-CoA) but only with low efficiency; its physiological substrates are branched-chain and C27 bile-acid CoA esters. Retained but noted as a minor/low-efficiency activity rather than a core function.
Reason: UniProt explicitly states ACOX2 oxidizes straight-chain acyl-CoAs (C10-CoA, C16-CoA) only with low efficiency; long-chain straight-chain oxidation is the physiological role of ACOX1, not ACOX2. The term is not wrong (there is measurable C16-CoA activity) but over-states its importance relative to the branched-chain/bile-acid core function.
Propagation Review
Root cause:
TERM SCOPING PROBLEM
Failure modes:
FUNCTIONAL DIVERGENCE
GRANULARITY MISMATCH
Sources checked:
UniProtKB:Q15067
SUPPORTS SOURCE BUT NOT TARGET
Long-chain acyl-CoA oxidase activity fits ACOX1-type members; ACOX2 oxidizes straight long-chain acyl-CoAs only with low efficiency, its physiological substrates being branched-chain and C27 bile-acid CoA esters.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
acyl CoAs such as C10-CoA and C16-CoA with low efficiency
|
|
GO:0005777
peroxisome
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred peroxisomal localization/activity. ACOX2 carries a C-terminal SKL (PTS1) signal and is directly demonstrated to be peroxisomal in human liver, and is active within the peroxisome.
Reason: Consistent with strong experimental evidence (IDA in PMID:8943006 and PMID:2079609; IMP in PMID:27884763) and the UniProt SUBCELLULAR LOCATION. is_active_in is appropriate for a matrix enzyme acting inside the peroxisome.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
SUBCELLULAR LOCATION: Peroxisome
|
|
GO:0050660
flavin adenine dinucleotide binding
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: FAD binding inferred phylogenetically. ACOX2 is a FAD-dependent flavoprotein oxidase; FAD is an essential cofactor for the oxidative dehydrogenation reaction.
Reason: Supported by the UniProt COFACTOR annotation (FAD) and by the flavoprotein character of the whole acyl-CoA oxidase family. Reactome also describes the ACOX2:FAD holoenzyme.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Name=FAD; Xref=ChEBI:CHEBI:57692
|
|
GO:0000038
very long-chain fatty acid metabolic process
|
IBA
GO_REF:0000033 |
MARK AS OVER ANNOTATED |
Summary: Involvement in very long-chain fatty acid metabolism inferred phylogenetically. ACOX2's physiological substrates are 2-methyl-branched-chain acyl-CoAs and C27 bile-acid intermediates, not straight very-long-chain fatty acids, which are the substrates of ACOX1. This appears to be over-propagation across the acyl-CoA oxidase clade.
Reason: Straight VLCFA beta-oxidation is the role of ACOX1 (palmitoyl-CoA oxidase). Human liver enzymology (PMID:2079609) distinguishes the separate trihydroxycoprostanoyl-CoA oxidase (ACOX2) from the palmitoyl-CoA oxidase, and UniProt notes only low-efficiency straight-chain activity for ACOX2. The VLCFA-metabolism assignment likely reflects family-level IBA transfer rather than ACOX2's actual physiological substrate range.
Propagation Review
Root cause:
PROPAGATION BAD
Failure modes:
FUNCTIONAL DIVERGENCE
Sources checked:
UniProtKB:Q15067
SUPPORTS SOURCE BUT NOT TARGET
Very-long-chain fatty acid metabolism is the role of ACOX1-type members; human liver enzymology (PMID:2079609) separates the trihydroxycoprostanoyl-CoA oxidase (ACOX2) from the palmitoyl-CoA oxidase, so this process should not transfer to ACOX2.
Supporting Evidence:
PMID:2079609
The results show that human liver, as rat liver, contains a separate trihydroxycoprostanoyl-CoA oxidase.
|
|
GO:0033791
3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: THCA-CoA oxidase (24-hydroxylase) activity inferred phylogenetically, with ACOX2 itself among the supporting genes (UniProtKB:Q99424 in the WITH/FROM). This is the bile-acid-specific reaction ACOX2 catalyzes on the C27 intermediate THCA-CoA.
Reason: Directly supported by experimental evidence (IDA in PMID:27884763) and by the UniProt catalytic activity for (25S)-THCA-CoA oxidation (Rhea:46728). This is a core molecular function.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Reaction=(25S)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oyl-
|
|
GO:0003997
acyl-CoA oxidase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Acyl-CoA oxidase activity (EC 1.3.3.6) assigned electronically from InterPro/Rhea. This is the defining molecular function of ACOX2 and is experimentally confirmed.
Reason: This parent MF term precisely captures ACOX2's biochemistry (a 2,3-saturated acyl-CoA + O2 -> a (2E)-enoyl-CoA + H2O2, EC 1.3.3.6), confirmed experimentally in PMID:27884763 and via the UniProt catalytic activity (Rhea:38959). It is the best single molecular function term for this enzyme.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Reaction=a 2,3-saturated acyl-CoA + O2 = a (2E)-enoyl-CoA + H2O2;
|
|
GO:0005777
peroxisome
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Peroxisomal localization assigned electronically (InterPro / UniProt SubCell). Confirmed by direct experimental evidence.
Reason: Consistent with the UniProt SUBCELLULAR LOCATION (Peroxisome) and multiple experimental annotations (IDA/IMP). The SKL C-terminal PTS1 targets the protein to the peroxisome.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
SUBCELLULAR LOCATION: Peroxisome
|
|
GO:0005782
peroxisomal matrix
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: Peroxisomal matrix localization assigned by ARBA machine-learning model. As a soluble PTS1-targeted matrix enzyme, ACOX2 resides in the peroxisomal matrix, consistent with Reactome placing its reactions in the peroxisomal matrix.
Reason: ACOX2 is a soluble matrix flavoenzyme (SKL/PTS1 import, not membrane-bound). This is a more specific and accurate compartment than the parent "peroxisome" term, and matches the Reactome curated location of its catalytic reactions.
Supporting Evidence:
Reactome:R-HSA-192335
This dehydrogenation reaction occurs in the peroxisomal matrix.
|
|
GO:0006631
fatty acid metabolic process
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Broad fatty acid metabolic process assigned from InterPro. Correct but general; ACOX2's specific role is captured by fatty acid beta-oxidation and bile acid biosynthetic process terms.
Reason: A true but broad parent process term. ACOX2 participates in fatty acid metabolism (peroxisomal beta-oxidation of branched-chain fatty acids). Kept as an accurate high-level annotation; more specific BP terms are also present.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Involved in peroxisomal beta-oxidation of branched-chain fatty acids (BCFAs) and bile acids intermediates.
|
|
GO:0006635
fatty acid beta-oxidation
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Fatty acid beta-oxidation assigned electronically from InterPro. ACOX2 catalyzes the first oxidase step of peroxisomal beta-oxidation, so this is an accurate parent of the more specific "fatty acid beta-oxidation using acyl-CoA oxidase" term.
Reason: Directly supported by the UniProt PATHWAY (peroxisomal fatty acid beta-oxidation) and by experimental data. This is a core biological process for ACOX2.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Lipid metabolism; peroxisomal fatty acid beta-oxidation.
|
|
GO:0016402
pristanoyl-CoA oxidase activity
|
IEA
GO_REF:0000116 |
ACCEPT |
Summary: Pristanoyl-CoA oxidase activity assigned from Rhea (RHEA:40459). ACOX2 oxidizes (2S)-pristanoyl-CoA, a 2-methyl-branched-chain fatty acyl-CoA, though it acts redundantly with ACOX3 for this substrate.
Reason: Supported by the UniProt catalytic activity for (2S)-pristanoyl-CoA (Rhea:40459, ECO:0000269|PubMed:29287774). This is a genuine branched-chain fatty acyl-CoA oxidase activity of ACOX2.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Reaction=(2S)-pristanoyl-CoA + O2 = (2E)-pristenoyl-CoA + H2O2;
|
|
GO:0016491
oxidoreductase activity
|
IEA
GO_REF:0000117 |
MARK AS OVER ANNOTATED |
Summary: Root-level oxidoreductase activity from ARBA. Correct but very general; ACOX2's oxidoreductase function is precisely captured by acyl-CoA oxidase activity.
Reason: This is a high-level grouping term that is technically true (ACOX2 is an oxidoreductase) but uninformative given the specific acyl-CoA oxidase activity (EC 1.3.3.6) is already annotated. Retained but flagged as too general.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
EC=1.3.3.6
|
|
GO:0016627
oxidoreductase activity, acting on the CH-CH group of donors
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Oxidoreductase acting on the CH-CH group of donors, from InterPro. This is the correct mechanistic class (introduction of a C2-C3 double bond), an intermediate parent of acyl-CoA oxidase activity.
Reason: Accurate mechanistic parent term: ACOX2 desaturates the alpha-beta (CH-CH) bond of the acyl-CoA. It is subsumed by the more specific acyl-CoA oxidase activity but is not incorrect. Kept as an accurate intermediate-level annotation.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
introduces a trans double bond between the alpha and beta carbons of the acyl CoA molecules
|
|
GO:0033540
fatty acid beta-oxidation using acyl-CoA oxidase
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: Fatty acid beta-oxidation using acyl-CoA oxidase, assigned by ARBA. This is the precise pathway term for ACOX2 and is also supported experimentally.
Reason: Duplicate of the experimentally supported (IDA/IMP, PMID:27884763) and IBA annotations for the same term. Precisely describes ACOX2's contribution to peroxisomal beta-oxidation.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Lipid metabolism; peroxisomal fatty acid beta-oxidation.
|
|
GO:0050660
flavin adenine dinucleotide binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: FAD binding assigned from InterPro. Duplicate of the IBA/ISS FAD-binding annotations; ACOX2 is a FAD-dependent flavoprotein.
Reason: Supported by the UniProt COFACTOR (FAD) annotation. FAD is the essential redox cofactor of this oxidase.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Name=FAD; Xref=ChEBI:CHEBI:57692
|
|
GO:0071949
FAD binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: FAD binding (GO:0071949) assigned from InterPro. Semantically equivalent to the GO:0050660 FAD-binding annotations; both describe binding of the FAD cofactor.
Reason: Supported by the UniProt COFACTOR (FAD) annotation. Retained; this is a valid (if redundant with GO:0050660) representation of FAD cofactor binding.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Name=FAD; Xref=ChEBI:CHEBI:57692
|
|
GO:0120523
medium-chain fatty acyl-CoA oxidase activity
|
IEA
GO_REF:0000116 |
MARK AS OVER ANNOTATED |
Summary: Medium-chain acyl-CoA oxidase activity from Rhea (RHEA:40179, decanoyl-CoA). ACOX2 can oxidize the medium-chain substrate decanoyl-CoA (C10-CoA), but UniProt characterizes straight-chain oxidation as low efficiency.
Reason: There is measurable in vitro activity on decanoyl-CoA (Rhea:40179, PubMed:29287774), so the term is not wrong, but UniProt explicitly notes straight-chain acyl-CoA oxidation (C10-CoA, C16-CoA) is low efficiency. This is a minor activity, not a core physiological function, which is branched-chain and bile-acid CoA-ester oxidation.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
acyl CoAs such as C10-CoA and C16-CoA with low efficiency
|
|
GO:0120524
long-chain fatty acyl-CoA oxidase activity
|
IEA
GO_REF:0000116 |
MARK AS OVER ANNOTATED |
Summary: Long-chain acyl-CoA oxidase activity from Rhea (RHEA:40167, hexadecanoyl-CoA). Duplicate of the IBA long-chain annotation; represents low-efficiency straight-chain activity.
Reason: In vitro C16-CoA (hexadecanoyl-CoA) oxidation exists (Rhea:40167), but UniProt states it is low efficiency; straight-chain long-chain oxidation is the physiological role of ACOX1. Flagged as over-annotation relative to ACOX2's branched-chain/bile-acid core.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
acyl CoAs such as C10-CoA and C16-CoA with low efficiency
|
|
GO:0005515
protein binding
|
IPI
PMID:28514442 Architecture of the human interactome defines protein commun... |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" from a high-throughput affinity-capture interactome screen (BioPlex; ACOX2 with STRN3, UniProtKB:Q13033). Uninformative molecular function.
Reason: Per curation guidelines, bare "protein binding" (GO:0005515) is uninformative. This interaction derives from a genome-scale interactome mapping study, not a functional characterization; there is no evidence it reflects a physiologically meaningful complex of ACOX2. Retained (not removed, per policy for experimental IPIs) but marked as over-annotated.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Q99424; Q13033: STRN3
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" from the HuRI binary interactome map (ACOX2 with DYNLT1, UniProtKB:P63172). Uninformative molecular function.
Reason: Bare "protein binding" from a systematic binary (Y2H) interactome screen is uninformative and does not point to a specific biochemical function of ACOX2. Retained per policy for experimental IPIs but flagged as over-annotated.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Q99424; P63172: DYNLT1
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" from a proteome-scale interactome network study (BioPlex 3.0; ACOX2 with STRN3, UniProtKB:Q13033). Uninformative molecular function.
Reason: Bare "protein binding" from a high-throughput interactome dataset is uninformative for curation and does not establish a functionally relevant ACOX2 complex. Retained per policy for experimental IPIs but flagged as over-annotated.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Q99424; Q13033: STRN3
|
|
GO:0006699
bile acid biosynthetic process
|
IDA
PMID:27884763 ACOX2 deficiency: An inborn error of bile acid synthesis ide... |
ACCEPT |
Summary: Direct experimental evidence that ACOX2 is involved in bile acid biosynthesis: patients with the R225W mutation accumulate C27 intermediates and lack C24 bile acids, and overexpression of wild-type (but not mutant) ACOX2 enhances biotransformation of THCA into cholic acid. This is a core biological process.
Reason: Strong IDA evidence from PMID:27884763 places ACOX2 in the peroxisomal side-chain shortening of C27 cholestanoic acids to C24 bile acids. This is one of ACOX2's two core physiological roles.
Supporting Evidence:
PMID:27884763
Acyl-CoA oxidase (ACOX2) is involved in the shortening of C27 cholesterol derivatives to generate C24 bile acids.
PMID:27884763
THCA biotransformation into cholic acid was enhanced in cells overexpressing ACOX2, but not in those overexpressing mutACOX2.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9033235 |
MARK AS OVER ANNOTATED |
Summary: Cytosol localization from a Reactome peroxisomal-import reaction (PEX5 cargo translocating from cytosol to the peroxisomal matrix). This reflects the transient cytosolic import intermediate of matrix proteins, not the compartment where ACOX2 is catalytically active.
Reason: ACOX2 is a PTS1 (SKL) matrix enzyme; peroxisomal matrix proteins are synthesized in the cytosol and imported post-translationally, so a transient cytosolic pool exists, but the functional/steady-state location is the peroxisomal matrix. The cytosol annotation captures the import-pathway transit state rather than the site of ACOX2 activity.
Supporting Evidence:
Reactome:R-HSA-9033235
Cargo of PEX5S,L translocates from the cytosol to the peroxisomal matrix
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9033236 |
MARK AS OVER ANNOTATED |
Summary: Cytosol localization from a Reactome peroxisomal-import docking reaction (PEX5:cargo binding the PEX13/PEX14 docking-translocation module). Like the sibling annotation, this reflects the cytosolic import intermediate, not ACOX2's catalytic compartment.
Reason: Same rationale as the other cytosol annotation: this is the transient cytosolic import/docking state of the PTS1-targeted matrix enzyme, not its functional location, which is the peroxisomal matrix.
Supporting Evidence:
Reactome:R-HSA-9033236
PEX5S,L:Cargo binds PEX13:PEX14:PEX2:PEX10:PEX12 (Docking and Translocation
|
|
GO:0005777
peroxisome
|
IMP
PMID:27884763 ACOX2 deficiency: An inborn error of bile acid synthesis ide... |
ACCEPT |
Summary: Peroxisomal localization confirmed by immunofluorescence in HepG2 cells overexpressing wild-type and R225W-mutant ACOX2; both showed peroxisomal localization. Direct experimental support for the peroxisome location.
Reason: PMID:27884763 experimentally demonstrates peroxisomal localization of ACOX2 (both WT and mutant). Consistent with the UniProt SUBCELLULAR LOCATION and the IDA localizations.
Supporting Evidence:
PMID:27884763
Immunofluorescence studies showed similar protein size and peroxisomal localization for both normal and mutated variants.
|
|
GO:0033540
fatty acid beta-oxidation using acyl-CoA oxidase
|
IDA
PMID:27884763 ACOX2 deficiency: An inborn error of bile acid synthesis ide... |
ACCEPT |
Summary: Direct experimental evidence for ACOX2's role in acyl-CoA-oxidase-mediated beta-oxidation, shown via its bile-acid intermediate (THCA) processing that requires functional ACOX2. Core biological process.
Reason: PMID:27884763 demonstrates that functional ACOX2 is required for the oxidase step that processes C27 bile-acid CoA intermediates during peroxisomal beta-oxidation. Precise pathway term.
Supporting Evidence:
PMID:27884763
THCA biotransformation into cholic acid was enhanced in cells overexpressing ACOX2, but not in those overexpressing mutACOX2.
|
|
GO:0033791
3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity
|
IDA
PMID:27884763 ACOX2 deficiency: An inborn error of bile acid synthesis ide... |
ACCEPT |
Summary: Direct experimental evidence for THCA-CoA oxidase activity: wild-type ACOX2, but not the R225W mutant, enhances biotransformation of THCA to cholic acid, establishing this specific catalytic activity on the C27 bile-acid intermediate. Core molecular function.
Reason: IDA evidence in PMID:27884763 directly supports ACOX2's activity on the C27 trihydroxycholestanoyl-CoA substrate. Corresponds to the UniProt catalytic activity (Rhea:46728) for (25S)-THCA-CoA oxidation. This is a core molecular function.
Supporting Evidence:
PMID:27884763
THCA biotransformation into cholic acid was enhanced in cells overexpressing ACOX2, but not in those overexpressing mutACOX2.
|
|
GO:0005777
peroxisome
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Peroxisomal localization transferred by sequence similarity from ACOX1 (UniProtKB:P07872). Consistent with the direct experimental peroxisomal localization of ACOX2.
Reason: Redundant with strong direct evidence (IDA/IMP) for peroxisomal localization. The SKL PTS1 signal and experimental data confirm the peroxisome location.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
SUBCELLULAR LOCATION: Peroxisome
|
|
GO:0033540
fatty acid beta-oxidation using acyl-CoA oxidase
|
IMP
PMID:27884763 ACOX2 deficiency: An inborn error of bile acid synthesis ide... |
ACCEPT |
Summary: Involvement in acyl-CoA-oxidase-mediated beta-oxidation supported by mutational phenotype: the R225W mutation reduces ACOX2 function, and patients accumulate C27 bile-acid intermediates with loss of C24 bile acids. Core biological process.
Reason: IMP evidence (loss-of-function R225W phenotype) in PMID:27884763 confirms ACOX2's requirement for the peroxisomal acyl-CoA-oxidase beta-oxidation of C27 intermediates.
Supporting Evidence:
PMID:27884763
The patient's serum and urine showed negligible amounts of C24 bile acids, but augmented levels of C27 intermediates
|
|
GO:0033791
3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: THCA-CoA oxidase activity transferred by sequence similarity from the rat ortholog (UniProtKB:O02767, THCC oxidase). Consistent with the direct experimental activity for human ACOX2.
Reason: Redundant with the IDA/IBA annotations for the same activity. ACOX2 is the human homolog of rat trihydroxycoprostanoyl-CoA oxidase, and the ISS transfer from the rat ortholog is well-founded.
Supporting Evidence:
PMID:8943006
the hBRCACox is the human homolog of rat trihydroxycoprostanoyl-CoA oxidase (rTHCCox)
|
|
GO:0042803
protein homodimerization activity
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Homodimerization activity transferred by sequence similarity from ACOX1 (UniProtKB:P07872). UniProt annotates ACOX2 as a homodimer (by similarity).
Reason: Supported by the UniProt SUBUNIT annotation (Homodimer, by similarity). Acyl-CoA oxidase family members characteristically form homodimers. Retained as a by-similarity structural/quaternary annotation.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
SUBUNIT: Homodimer.
|
|
GO:0050660
flavin adenine dinucleotide binding
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: FAD binding transferred by sequence similarity from ACOX1 (UniProtKB:P07872). ACOX2 is a FAD flavoprotein. Redundant with the IBA/IEA FAD-binding annotations.
Reason: Supported by the UniProt COFACTOR (FAD) annotation and the flavoprotein nature of the acyl-CoA oxidase family. FAD is the essential redox cofactor.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Name=FAD; Xref=ChEBI:CHEBI:57692
|
|
GO:0005782
peroxisomal matrix
|
TAS
Reactome:R-HSA-192335 |
ACCEPT |
Summary: Peroxisomal matrix localization from Reactome, tied to the curated reaction in which ACOX2 dehydrogenates 25(S) THCA-CoA in the peroxisomal matrix. Accurate compartment for this soluble matrix enzyme.
Reason: Reactome explicitly places the ACOX2-catalyzed THCA-CoA dehydrogenation in the peroxisomal matrix. This is the accurate, specific compartment for the soluble PTS1-targeted enzyme.
Supporting Evidence:
Reactome:R-HSA-192335
This dehydrogenation reaction occurs in the peroxisomal matrix.
|
|
GO:0005782
peroxisomal matrix
|
TAS
Reactome:R-HSA-193369 |
ACCEPT |
Summary: Peroxisomal matrix localization from Reactome, tied to the curated reaction in which ACOX2 dehydrogenates 25(S) DHCA-CoA. Accurate compartment for this soluble matrix enzyme.
Reason: Reactome places the ACOX2-catalyzed DHCA-CoA dehydrogenation in the peroxisomal matrix, consistent with the enzyme's soluble matrix localization. Accurate, specific compartment.
Supporting Evidence:
Reactome:R-HSA-193369
25(S) DHCA-CoA is dehydrogenated to 25(S) 3alpha,7alpha-dihydroxy-5beta-cholest-24-enoyl-CoA
|
|
GO:0005782
peroxisomal matrix
|
TAS
Reactome:R-HSA-389889 |
ACCEPT |
Summary: Peroxisomal matrix localization from Reactome, tied to the curated reaction in which ACOX2:FAD oxidizes (2S)-pristanoyl-CoA. Accurate compartment for this soluble matrix enzyme.
Reason: Reactome places the ACOX2-catalyzed pristanoyl-CoA oxidation in the peroxisomal matrix, consistent with the enzyme's soluble matrix localization. Accurate, specific compartment.
Supporting Evidence:
Reactome:R-HSA-389889
monomeric peroxisomal ACOX2 (bound to FAD cofactor) catalyzes the reaction of (2S)-pristanoyl-CoA
|
|
GO:0005782
peroxisomal matrix
|
TAS
Reactome:R-HSA-9033235 |
ACCEPT |
Summary: Peroxisomal matrix localization from Reactome, from the peroxisomal-import reaction in which PEX5 cargo (including ACOX2) is translocated into the matrix. Accurate destination compartment.
Reason: The reaction describes cargo translocation into the peroxisomal matrix, which is ACOX2's functional destination. Consistent with the other matrix annotations and experimental data.
Supporting Evidence:
Reactome:R-HSA-9033235
Cargo of PEX5S,L translocates from the cytosol to the peroxisomal matrix
|
|
GO:0005777
peroxisome
|
IDA
PMID:8943006 Molecular characterization of the human peroxisomal branched... |
ACCEPT |
Summary: Direct experimental peroxisomal localization: the human branched-chain acyl-CoA oxidase carries a C-terminal SKL PTS1 signal and was shown to be peroxisomal (and absent from Zellweger livers by immunoblot/immunocytochemistry). Core localization.
Reason: PMID:8943006 provides direct evidence for peroxisomal localization (SKL PTS1; absence in Zellweger patients, a peroxisome biogenesis disorder). Strong support for the peroxisome location.
Supporting Evidence:
PMID:8943006
The C-terminal tripeptide of the protein is SKL, a known peroxisome targeting signal.
|
|
GO:0005777
peroxisome
|
IDA
PMID:2079609 Separate peroxisomal oxidases for fatty acyl-CoAs and trihyd... |
ACCEPT |
Summary: Peroxisomal localization inferred from human liver enzymology establishing a separate peroxisomal trihydroxycoprostanoyl-CoA oxidase (ACOX2), distinct from palmitoyl-CoA oxidase, catalyzing the first step of peroxisomal beta-oxidation.
Reason: PMID:2079609 demonstrates a distinct peroxisomal trihydroxycoprostanoyl-CoA oxidase in human liver (i.e. ACOX2), supporting its peroxisomal localization. Consistent with all other localization evidence.
Supporting Evidence:
PMID:2079609
Fatty acyl-CoAs as well as the CoA esters of the bile acid intermediates di- and trihydroxycoprostanic acids are beta-oxidized in peroxisomes.
|
Q: What is the relative in vivo contribution of ACOX2 vs ACOX3 to pristanoyl-CoA / branched-chain fatty acid beta-oxidation in human tissues, given the reported redundancy?
Q: Do the STRN3 and DYNLT1 interactions reported in high-throughput screens have any physiological relevance to ACOX2 peroxisomal function or regulation?
Experiment: Quantitative enzyme kinetics of purified human ACOX2 on THCA-CoA, DHCA-CoA, (2S)-pristanoyl-CoA, and straight-chain acyl-CoAs (C10, C16) to define physiological substrate preference and confirm the low-efficiency straight-chain activity.
Experiment: Tissue-specific metabolic profiling (bile-acid intermediates, branched-chain fatty acids) in ACOX2-knockout vs ACOX3-knockout models to disentangle the overlapping branched-chain fatty acid roles.
UniProtKB: Q99424; HGNC:120; gene ACOX2 (chromosome 3p14.3). 681 aa; C-terminal SKL
peroxisomal targeting signal (PTS1). EC 1.3.3.6. FAD flavoprotein. Homodimer (by similarity).
Deep research note: falcon deep-research provider is out of credits (HTTP 402), so no
-deep-research-falcon.md was generated. This review is grounded in the UniProt record,
the seeded GOA, and cached publications only.
ACOX2 is the human peroxisomal branched-chain acyl-CoA oxidase (originally "hBRCACox";
homolog of rat trihydroxycoprostanoyl-CoA / THCC oxidase). It is a FAD-dependent oxidase
that catalyses the first, oxygen-dependent, rate-limiting dehydrogenation step of
peroxisomal beta-oxidation, removing two hydrogens and introducing a trans-2,3 double bond
into the acyl-CoA, producing H2O2 as a byproduct (UniProt FUNCTION; EC 1.3.3.6).
Two physiological substrate classes:
1. C27 bile-acid intermediates — (25S)-THCA-CoA and DHCA-CoA. ACOX2 initiates the
side-chain shortening that converts C27 cholestanoic acids to the mature C24 bile acids
(cholic / chenodeoxycholic). PMID:27884763
2. 2-methyl-branched-chain fatty acyl-CoAs — e.g. (2S)-pristanoyl-CoA; stereospecific
for (2S)-methyl isomers. Redundant with ACOX3 for pristanoyl-CoA (PMID:29287774, per
UniProt). Also mono-methyl branched-chain FAs (mmBCFA) in brown adipose tissue (by
similarity to mouse Q9QXD1). Low-efficiency straight-chain activity (C10, C16).
The 1990 human-liver enzymology paper PMID:2079609 established that human liver contains a
separate trihydroxycoprostanoyl-CoA oxidase distinct from palmitoyl-CoA oxidase (ACOX1),
explaining why bile-acid metabolism is normal in ACOX1 deficiency — this separate THCC
oxidase is ACOX2.
Peroxisome / peroxisomal matrix. Direct protein evidence in human liver
PMID:8943006 (immunocytochemistry; SKL PTS1; absent in Zellweger livers) and
PMID:2079609. IMP peroxisomal localization confirmed for both WT and R225W mutant in
HepG2 PMID:27884763. The Reactome TAS cytosol annotations refer to the peroxisomal-import
transit state (PEX5 cargo in cytosol before matrix translocation), not the site of
catalytic activity.
ACOX2 deficiency / Congenital bile acid synthesis defect 6 (CBAS6; MIM:617308) —
autosomal recessive inborn error of bile-acid synthesis. Accumulation of toxic C27
intermediates (THCA, DHCA), negligible C24 bile acids, persistent hypertransaminasemia /
liver fibrosis; variable neurological features (ataxia, cognitive impairment). Known
variants: R225W PMID:27884763 and a large N-terminal deletion (69-682 del) [PMID:27647924,
via UniProt]. Phytanic/pristanic acids remain normal (redundancy with ACOX3 for BCFA).
id: Q99424
gene_symbol: ACOX2
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
ACOX2 is the human peroxisomal branched-chain acyl-CoA oxidase (EC 1.3.3.6), a
FAD-dependent flavoenzyme of the acyl-CoA oxidase family. It catalyzes the first,
oxygen-dependent and rate-limiting dehydrogenation step of peroxisomal beta-oxidation,
removing two hydrogens and introducing a trans-2,3 double bond into the acyl-CoA
substrate while generating hydrogen peroxide as a byproduct. Its principal physiological
substrates are the C27 bile-acid intermediates (25S)-3alpha,7alpha,12alpha-trihydroxy-
cholestanoyl-CoA (THCA-CoA) and dihydroxycholestanoyl-CoA (DHCA-CoA); ACOX2 initiates the
side-chain shortening that converts these C27 cholestanoic acids into the mature C24 bile
acids (cholic and chenodeoxycholic acid). It also oxidizes 2-methyl-branched-chain fatty
acyl-CoA esters such as (2S)-pristanoyl-CoA (with redundancy to ACOX3) and monomethyl
branched-chain fatty acids, acting stereospecifically on (2S)-methyl isomers, and can
oxidize straight-chain acyl-CoAs with low efficiency. ACOX2 is a homodimer that resides in
the peroxisomal matrix, imported via its C-terminal SKL (PTS1) targeting signal. It is
expressed in many tissues, most abundantly in liver, kidney and heart. Loss-of-function
causes ACOX2 deficiency (congenital bile acid synthesis defect 6, CBAS6), an autosomal
recessive disorder marked by accumulation of toxic C27 bile-acid intermediates, persistent
hypertransaminasemia and liver fibrosis, with variable neurological features.
existing_annotations:
- term:
id: GO:0005504
label: fatty acid binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Fatty acid binding propagated by phylogenetic inference. Substrate binding is implicit
in the acyl-CoA oxidase catalytic mechanism, but a bare "fatty acid binding" molecular
function term is uninformative for this enzyme, whose informative MF is its acyl-CoA
oxidase (dehydrogenase) activity. Retained but flagged as an over-annotation.
action: MARK_AS_OVER_ANNOTATED
reason: >-
ACOX2 acts on acyl-CoA thioesters (branched-chain and C27 bile-acid CoA esters), not
on free fatty acids, and its informative molecular function is captured by the acyl-CoA
oxidase activity terms. A generic "fatty acid binding" adds little functional
information and is more precisely represented by the catalytic MF terms.
propagation_review:
root_cause: TERM_SCOPING_PROBLEM
failure_modes:
- GRANULARITY_MISMATCH
- ROLE_CONFLATION
source_entities:
- source_id: PANTHER:PTN000097533
source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
comment: >-
Family-level "fatty acid binding" propagated from the acyl-CoA oxidase clade; ACOX2
acts on acyl-CoA thioesters, and the informative MF is its acyl-CoA oxidase activity.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: >-
Involved in peroxisomal beta-oxidation of branched-chain
fatty acids (BCFAs) and bile acids intermediates.
- term:
id: GO:0033540
label: fatty acid beta-oxidation using acyl-CoA oxidase
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetically inferred involvement in fatty acid beta-oxidation via an acyl-CoA
oxidase. This is exactly the pathway ACOX2 participates in, catalyzing the first
oxidase step of peroxisomal beta-oxidation of branched-chain and bile-acid CoA esters.
action: ACCEPT
reason: >-
Directly supported by experimental data (IDA/IMP from PMID:27884763) and by the UniProt
PATHWAY assignment to peroxisomal fatty acid beta-oxidation. The IBA is at an
appropriate level of specificity for an acyl-CoA-oxidase family enzyme.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'Lipid metabolism; peroxisomal fatty acid beta-oxidation.'
- term:
id: GO:0120524
label: long-chain fatty acyl-CoA oxidase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Long-chain acyl-CoA oxidase activity inferred phylogenetically. ACOX2 can oxidize
straight-chain long-chain acyl-CoAs (e.g. hexadecanoyl-CoA/C16-CoA) but only with low
efficiency; its physiological substrates are branched-chain and C27 bile-acid CoA
esters. Retained but noted as a minor/low-efficiency activity rather than a core function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
UniProt explicitly states ACOX2 oxidizes straight-chain acyl-CoAs (C10-CoA, C16-CoA)
only with low efficiency; long-chain straight-chain oxidation is the physiological role
of ACOX1, not ACOX2. The term is not wrong (there is measurable C16-CoA activity) but
over-states its importance relative to the branched-chain/bile-acid core function.
propagation_review:
root_cause: TERM_SCOPING_PROBLEM
failure_modes:
- FUNCTIONAL_DIVERGENCE
- GRANULARITY_MISMATCH
source_entities:
- source_id: UniProtKB:Q15067
source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
comment: >-
Long-chain acyl-CoA oxidase activity fits ACOX1-type members; ACOX2 oxidizes
straight long-chain acyl-CoAs only with low efficiency, its physiological substrates
being branched-chain and C27 bile-acid CoA esters.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'acyl CoAs such as C10-CoA and C16-CoA with low efficiency'
- term:
id: GO:0005777
label: peroxisome
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
Phylogenetically inferred peroxisomal localization/activity. ACOX2 carries a C-terminal
SKL (PTS1) signal and is directly demonstrated to be peroxisomal in human liver, and is
active within the peroxisome.
action: ACCEPT
reason: >-
Consistent with strong experimental evidence (IDA in PMID:8943006 and PMID:2079609; IMP
in PMID:27884763) and the UniProt SUBCELLULAR LOCATION. is_active_in is appropriate for
a matrix enzyme acting inside the peroxisome.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Peroxisome'
- term:
id: GO:0050660
label: flavin adenine dinucleotide binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
FAD binding inferred phylogenetically. ACOX2 is a FAD-dependent flavoprotein oxidase;
FAD is an essential cofactor for the oxidative dehydrogenation reaction.
action: ACCEPT
reason: >-
Supported by the UniProt COFACTOR annotation (FAD) and by the flavoprotein character of
the whole acyl-CoA oxidase family. Reactome also describes the ACOX2:FAD holoenzyme.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'Name=FAD; Xref=ChEBI:CHEBI:57692'
- term:
id: GO:0000038
label: very long-chain fatty acid metabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Involvement in very long-chain fatty acid metabolism inferred phylogenetically. ACOX2's
physiological substrates are 2-methyl-branched-chain acyl-CoAs and C27 bile-acid
intermediates, not straight very-long-chain fatty acids, which are the substrates of
ACOX1. This appears to be over-propagation across the acyl-CoA oxidase clade.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Straight VLCFA beta-oxidation is the role of ACOX1 (palmitoyl-CoA oxidase). Human liver
enzymology (PMID:2079609) distinguishes the separate trihydroxycoprostanoyl-CoA oxidase
(ACOX2) from the palmitoyl-CoA oxidase, and UniProt notes only low-efficiency
straight-chain activity for ACOX2. The VLCFA-metabolism assignment likely reflects
family-level IBA transfer rather than ACOX2's actual physiological substrate range.
propagation_review:
root_cause: PROPAGATION_BAD
failure_modes:
- FUNCTIONAL_DIVERGENCE
source_entities:
- source_id: UniProtKB:Q15067
source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
comment: >-
Very-long-chain fatty acid metabolism is the role of ACOX1-type members; human liver
enzymology (PMID:2079609) separates the trihydroxycoprostanoyl-CoA oxidase (ACOX2)
from the palmitoyl-CoA oxidase, so this process should not transfer to ACOX2.
supported_by:
- reference_id: PMID:2079609
supporting_text: >-
The results show that human liver, as rat liver, contains a separate
trihydroxycoprostanoyl-CoA oxidase.
- term:
id: GO:0033791
label: 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase
activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
THCA-CoA oxidase (24-hydroxylase) activity inferred phylogenetically, with ACOX2 itself
among the supporting genes (UniProtKB:Q99424 in the WITH/FROM). This is the
bile-acid-specific reaction ACOX2 catalyzes on the C27 intermediate THCA-CoA.
action: ACCEPT
reason: >-
Directly supported by experimental evidence (IDA in PMID:27884763) and by the UniProt
catalytic activity for (25S)-THCA-CoA oxidation (Rhea:46728). This is a core molecular
function.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: >-
Reaction=(25S)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oyl-
- term:
id: GO:0003997
label: acyl-CoA oxidase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Acyl-CoA oxidase activity (EC 1.3.3.6) assigned electronically from InterPro/Rhea. This
is the defining molecular function of ACOX2 and is experimentally confirmed.
action: ACCEPT
reason: >-
This parent MF term precisely captures ACOX2's biochemistry (a 2,3-saturated acyl-CoA +
O2 -> a (2E)-enoyl-CoA + H2O2, EC 1.3.3.6), confirmed experimentally in PMID:27884763
and via the UniProt catalytic activity (Rhea:38959). It is the best single molecular
function term for this enzyme.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'Reaction=a 2,3-saturated acyl-CoA + O2 = a (2E)-enoyl-CoA + H2O2;'
- term:
id: GO:0005777
label: peroxisome
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: located_in
review:
summary: >-
Peroxisomal localization assigned electronically (InterPro / UniProt SubCell). Confirmed
by direct experimental evidence.
action: ACCEPT
reason: >-
Consistent with the UniProt SUBCELLULAR LOCATION (Peroxisome) and multiple experimental
annotations (IDA/IMP). The SKL C-terminal PTS1 targets the protein to the peroxisome.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Peroxisome'
- term:
id: GO:0005782
label: peroxisomal matrix
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: located_in
review:
summary: >-
Peroxisomal matrix localization assigned by ARBA machine-learning model. As a soluble
PTS1-targeted matrix enzyme, ACOX2 resides in the peroxisomal matrix, consistent with
Reactome placing its reactions in the peroxisomal matrix.
action: ACCEPT
reason: >-
ACOX2 is a soluble matrix flavoenzyme (SKL/PTS1 import, not membrane-bound). This is a
more specific and accurate compartment than the parent "peroxisome" term, and matches
the Reactome curated location of its catalytic reactions.
supported_by:
- reference_id: Reactome:R-HSA-192335
supporting_text: This dehydrogenation reaction occurs in the peroxisomal matrix.
- term:
id: GO:0006631
label: fatty acid metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
Broad fatty acid metabolic process assigned from InterPro. Correct but general; ACOX2's
specific role is captured by fatty acid beta-oxidation and bile acid biosynthetic
process terms.
action: ACCEPT
reason: >-
A true but broad parent process term. ACOX2 participates in fatty acid metabolism
(peroxisomal beta-oxidation of branched-chain fatty acids). Kept as an accurate
high-level annotation; more specific BP terms are also present.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: >-
Involved in peroxisomal beta-oxidation of branched-chain
fatty acids (BCFAs) and bile acids intermediates.
- term:
id: GO:0006635
label: fatty acid beta-oxidation
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
Fatty acid beta-oxidation assigned electronically from InterPro. ACOX2 catalyzes the
first oxidase step of peroxisomal beta-oxidation, so this is an accurate parent of the
more specific "fatty acid beta-oxidation using acyl-CoA oxidase" term.
action: ACCEPT
reason: >-
Directly supported by the UniProt PATHWAY (peroxisomal fatty acid beta-oxidation) and
by experimental data. This is a core biological process for ACOX2.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'Lipid metabolism; peroxisomal fatty acid beta-oxidation.'
- term:
id: GO:0016402
label: pristanoyl-CoA oxidase activity
evidence_type: IEA
original_reference_id: GO_REF:0000116
qualifier: enables
review:
summary: >-
Pristanoyl-CoA oxidase activity assigned from Rhea (RHEA:40459). ACOX2 oxidizes
(2S)-pristanoyl-CoA, a 2-methyl-branched-chain fatty acyl-CoA, though it acts
redundantly with ACOX3 for this substrate.
action: ACCEPT
reason: >-
Supported by the UniProt catalytic activity for (2S)-pristanoyl-CoA (Rhea:40459,
ECO:0000269|PubMed:29287774). This is a genuine branched-chain fatty acyl-CoA oxidase
activity of ACOX2.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'Reaction=(2S)-pristanoyl-CoA + O2 = (2E)-pristenoyl-CoA + H2O2;'
- term:
id: GO:0016491
label: oxidoreductase activity
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: enables
review:
summary: >-
Root-level oxidoreductase activity from ARBA. Correct but very general; ACOX2's
oxidoreductase function is precisely captured by acyl-CoA oxidase activity.
action: MARK_AS_OVER_ANNOTATED
reason: >-
This is a high-level grouping term that is technically true (ACOX2 is an oxidoreductase)
but uninformative given the specific acyl-CoA oxidase activity (EC 1.3.3.6) is already
annotated. Retained but flagged as too general.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: EC=1.3.3.6
- term:
id: GO:0016627
label: oxidoreductase activity, acting on the CH-CH group of donors
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
Oxidoreductase acting on the CH-CH group of donors, from InterPro. This is the correct
mechanistic class (introduction of a C2-C3 double bond), an intermediate parent of
acyl-CoA oxidase activity.
action: ACCEPT
reason: >-
Accurate mechanistic parent term: ACOX2 desaturates the alpha-beta (CH-CH) bond of the
acyl-CoA. It is subsumed by the more specific acyl-CoA oxidase activity but is not
incorrect. Kept as an accurate intermediate-level annotation.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: >-
introduces a trans double bond between the alpha and beta
carbons of the acyl CoA molecules
- term:
id: GO:0033540
label: fatty acid beta-oxidation using acyl-CoA oxidase
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: >-
Fatty acid beta-oxidation using acyl-CoA oxidase, assigned by ARBA. This is the precise
pathway term for ACOX2 and is also supported experimentally.
action: ACCEPT
reason: >-
Duplicate of the experimentally supported (IDA/IMP, PMID:27884763) and IBA annotations
for the same term. Precisely describes ACOX2's contribution to peroxisomal
beta-oxidation.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'Lipid metabolism; peroxisomal fatty acid beta-oxidation.'
- term:
id: GO:0050660
label: flavin adenine dinucleotide binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
FAD binding assigned from InterPro. Duplicate of the IBA/ISS FAD-binding annotations;
ACOX2 is a FAD-dependent flavoprotein.
action: ACCEPT
reason: >-
Supported by the UniProt COFACTOR (FAD) annotation. FAD is the essential redox cofactor
of this oxidase.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'Name=FAD; Xref=ChEBI:CHEBI:57692'
- term:
id: GO:0071949
label: FAD binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
FAD binding (GO:0071949) assigned from InterPro. Semantically equivalent to the
GO:0050660 FAD-binding annotations; both describe binding of the FAD cofactor.
action: ACCEPT
reason: >-
Supported by the UniProt COFACTOR (FAD) annotation. Retained; this is a valid (if
redundant with GO:0050660) representation of FAD cofactor binding.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'Name=FAD; Xref=ChEBI:CHEBI:57692'
- term:
id: GO:0120523
label: medium-chain fatty acyl-CoA oxidase activity
evidence_type: IEA
original_reference_id: GO_REF:0000116
qualifier: enables
review:
summary: >-
Medium-chain acyl-CoA oxidase activity from Rhea (RHEA:40179, decanoyl-CoA). ACOX2 can
oxidize the medium-chain substrate decanoyl-CoA (C10-CoA), but UniProt characterizes
straight-chain oxidation as low efficiency.
action: MARK_AS_OVER_ANNOTATED
reason: >-
There is measurable in vitro activity on decanoyl-CoA (Rhea:40179, PubMed:29287774), so
the term is not wrong, but UniProt explicitly notes straight-chain acyl-CoA oxidation
(C10-CoA, C16-CoA) is low efficiency. This is a minor activity, not a core physiological
function, which is branched-chain and bile-acid CoA-ester oxidation.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'acyl CoAs such as C10-CoA and C16-CoA with low efficiency'
- term:
id: GO:0120524
label: long-chain fatty acyl-CoA oxidase activity
evidence_type: IEA
original_reference_id: GO_REF:0000116
qualifier: enables
review:
summary: >-
Long-chain acyl-CoA oxidase activity from Rhea (RHEA:40167, hexadecanoyl-CoA). Duplicate
of the IBA long-chain annotation; represents low-efficiency straight-chain activity.
action: MARK_AS_OVER_ANNOTATED
reason: >-
In vitro C16-CoA (hexadecanoyl-CoA) oxidation exists (Rhea:40167), but UniProt states it
is low efficiency; straight-chain long-chain oxidation is the physiological role of
ACOX1. Flagged as over-annotation relative to ACOX2's branched-chain/bile-acid core.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'acyl CoAs such as C10-CoA and C16-CoA with low efficiency'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28514442
qualifier: enables
review:
summary: >-
Bare "protein binding" from a high-throughput affinity-capture interactome screen
(BioPlex; ACOX2 with STRN3, UniProtKB:Q13033). Uninformative molecular function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Per curation guidelines, bare "protein binding" (GO:0005515) is uninformative. This
interaction derives from a genome-scale interactome mapping study, not a functional
characterization; there is no evidence it reflects a physiologically meaningful complex
of ACOX2. Retained (not removed, per policy for experimental IPIs) but marked as
over-annotated.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'Q99424; Q13033: STRN3'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: >-
Bare "protein binding" from the HuRI binary interactome map (ACOX2 with DYNLT1,
UniProtKB:P63172). Uninformative molecular function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Bare "protein binding" from a systematic binary (Y2H) interactome screen is
uninformative and does not point to a specific biochemical function of ACOX2. Retained
per policy for experimental IPIs but flagged as over-annotated.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'Q99424; P63172: DYNLT1'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: >-
Bare "protein binding" from a proteome-scale interactome network study (BioPlex 3.0;
ACOX2 with STRN3, UniProtKB:Q13033). Uninformative molecular function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Bare "protein binding" from a high-throughput interactome dataset is uninformative for
curation and does not establish a functionally relevant ACOX2 complex. Retained per
policy for experimental IPIs but flagged as over-annotated.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'Q99424; Q13033: STRN3'
- term:
id: GO:0006699
label: bile acid biosynthetic process
evidence_type: IDA
original_reference_id: PMID:27884763
qualifier: involved_in
review:
summary: >-
Direct experimental evidence that ACOX2 is involved in bile acid biosynthesis: patients
with the R225W mutation accumulate C27 intermediates and lack C24 bile acids, and
overexpression of wild-type (but not mutant) ACOX2 enhances biotransformation of THCA
into cholic acid. This is a core biological process.
action: ACCEPT
reason: >-
Strong IDA evidence from PMID:27884763 places ACOX2 in the peroxisomal side-chain
shortening of C27 cholestanoic acids to C24 bile acids. This is one of ACOX2's two core
physiological roles.
supported_by:
- reference_id: PMID:27884763
supporting_text: >-
Acyl-CoA oxidase (ACOX2) is involved in the shortening of C27
cholesterol derivatives to generate C24 bile acids.
- reference_id: PMID:27884763
supporting_text: >-
THCA biotransformation into cholic acid was enhanced in cells overexpressing
ACOX2, but not in those overexpressing mutACOX2.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9033235
qualifier: located_in
review:
summary: >-
Cytosol localization from a Reactome peroxisomal-import reaction (PEX5 cargo
translocating from cytosol to the peroxisomal matrix). This reflects the transient
cytosolic import intermediate of matrix proteins, not the compartment where ACOX2 is
catalytically active.
action: MARK_AS_OVER_ANNOTATED
reason: >-
ACOX2 is a PTS1 (SKL) matrix enzyme; peroxisomal matrix proteins are synthesized in the
cytosol and imported post-translationally, so a transient cytosolic pool exists, but the
functional/steady-state location is the peroxisomal matrix. The cytosol annotation
captures the import-pathway transit state rather than the site of ACOX2 activity.
supported_by:
- reference_id: Reactome:R-HSA-9033235
supporting_text: Cargo of PEX5S,L translocates from the cytosol to the peroxisomal matrix
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9033236
qualifier: located_in
review:
summary: >-
Cytosol localization from a Reactome peroxisomal-import docking reaction (PEX5:cargo
binding the PEX13/PEX14 docking-translocation module). Like the sibling annotation, this
reflects the cytosolic import intermediate, not ACOX2's catalytic compartment.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Same rationale as the other cytosol annotation: this is the transient cytosolic
import/docking state of the PTS1-targeted matrix enzyme, not its functional location,
which is the peroxisomal matrix.
supported_by:
- reference_id: Reactome:R-HSA-9033236
supporting_text: >-
PEX5S,L:Cargo binds PEX13:PEX14:PEX2:PEX10:PEX12 (Docking and Translocation
- term:
id: GO:0005777
label: peroxisome
evidence_type: IMP
original_reference_id: PMID:27884763
qualifier: located_in
review:
summary: >-
Peroxisomal localization confirmed by immunofluorescence in HepG2 cells overexpressing
wild-type and R225W-mutant ACOX2; both showed peroxisomal localization. Direct
experimental support for the peroxisome location.
action: ACCEPT
reason: >-
PMID:27884763 experimentally demonstrates peroxisomal localization of ACOX2 (both WT and
mutant). Consistent with the UniProt SUBCELLULAR LOCATION and the IDA localizations.
supported_by:
- reference_id: PMID:27884763
supporting_text: >-
Immunofluorescence studies showed similar
protein size and peroxisomal localization for both normal and mutated variants.
- term:
id: GO:0033540
label: fatty acid beta-oxidation using acyl-CoA oxidase
evidence_type: IDA
original_reference_id: PMID:27884763
qualifier: involved_in
review:
summary: >-
Direct experimental evidence for ACOX2's role in acyl-CoA-oxidase-mediated
beta-oxidation, shown via its bile-acid intermediate (THCA) processing that requires
functional ACOX2. Core biological process.
action: ACCEPT
reason: >-
PMID:27884763 demonstrates that functional ACOX2 is required for the oxidase step that
processes C27 bile-acid CoA intermediates during peroxisomal beta-oxidation. Precise
pathway term.
supported_by:
- reference_id: PMID:27884763
supporting_text: >-
THCA biotransformation into cholic acid was enhanced in cells overexpressing
ACOX2, but not in those overexpressing mutACOX2.
- term:
id: GO:0033791
label: 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase
activity
evidence_type: IDA
original_reference_id: PMID:27884763
qualifier: enables
review:
summary: >-
Direct experimental evidence for THCA-CoA oxidase activity: wild-type ACOX2, but not the
R225W mutant, enhances biotransformation of THCA to cholic acid, establishing this
specific catalytic activity on the C27 bile-acid intermediate. Core molecular function.
action: ACCEPT
reason: >-
IDA evidence in PMID:27884763 directly supports ACOX2's activity on the C27
trihydroxycholestanoyl-CoA substrate. Corresponds to the UniProt catalytic activity
(Rhea:46728) for (25S)-THCA-CoA oxidation. This is a core molecular function.
supported_by:
- reference_id: PMID:27884763
supporting_text: >-
THCA biotransformation into cholic acid was enhanced in cells overexpressing
ACOX2, but not in those overexpressing mutACOX2.
- term:
id: GO:0005777
label: peroxisome
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: located_in
review:
summary: >-
Peroxisomal localization transferred by sequence similarity from ACOX1 (UniProtKB:P07872).
Consistent with the direct experimental peroxisomal localization of ACOX2.
action: ACCEPT
reason: >-
Redundant with strong direct evidence (IDA/IMP) for peroxisomal localization. The SKL
PTS1 signal and experimental data confirm the peroxisome location.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Peroxisome'
- term:
id: GO:0033540
label: fatty acid beta-oxidation using acyl-CoA oxidase
evidence_type: IMP
original_reference_id: PMID:27884763
qualifier: involved_in
review:
summary: >-
Involvement in acyl-CoA-oxidase-mediated beta-oxidation supported by mutational
phenotype: the R225W mutation reduces ACOX2 function, and patients accumulate C27
bile-acid intermediates with loss of C24 bile acids. Core biological process.
action: ACCEPT
reason: >-
IMP evidence (loss-of-function R225W phenotype) in PMID:27884763 confirms ACOX2's
requirement for the peroxisomal acyl-CoA-oxidase beta-oxidation of C27 intermediates.
supported_by:
- reference_id: PMID:27884763
supporting_text: >-
The patient's serum and urine showed negligible amounts of C24 bile
acids, but augmented levels of C27 intermediates
- term:
id: GO:0033791
label: 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase
activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: >-
THCA-CoA oxidase activity transferred by sequence similarity from the rat ortholog
(UniProtKB:O02767, THCC oxidase). Consistent with the direct experimental activity for
human ACOX2.
action: ACCEPT
reason: >-
Redundant with the IDA/IBA annotations for the same activity. ACOX2 is the human homolog
of rat trihydroxycoprostanoyl-CoA oxidase, and the ISS transfer from the rat ortholog is
well-founded.
supported_by:
- reference_id: PMID:8943006
supporting_text: >-
the hBRCACox is the human homolog of rat trihydroxycoprostanoyl-CoA
oxidase (rTHCCox)
- term:
id: GO:0042803
label: protein homodimerization activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: >-
Homodimerization activity transferred by sequence similarity from ACOX1 (UniProtKB:P07872).
UniProt annotates ACOX2 as a homodimer (by similarity).
action: ACCEPT
reason: >-
Supported by the UniProt SUBUNIT annotation (Homodimer, by similarity). Acyl-CoA oxidase
family members characteristically form homodimers. Retained as a by-similarity
structural/quaternary annotation.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'SUBUNIT: Homodimer.'
- term:
id: GO:0050660
label: flavin adenine dinucleotide binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: >-
FAD binding transferred by sequence similarity from ACOX1 (UniProtKB:P07872). ACOX2 is a
FAD flavoprotein. Redundant with the IBA/IEA FAD-binding annotations.
action: ACCEPT
reason: >-
Supported by the UniProt COFACTOR (FAD) annotation and the flavoprotein nature of the
acyl-CoA oxidase family. FAD is the essential redox cofactor.
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'Name=FAD; Xref=ChEBI:CHEBI:57692'
- term:
id: GO:0005782
label: peroxisomal matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-192335
qualifier: located_in
review:
summary: >-
Peroxisomal matrix localization from Reactome, tied to the curated reaction in which
ACOX2 dehydrogenates 25(S) THCA-CoA in the peroxisomal matrix. Accurate compartment for
this soluble matrix enzyme.
action: ACCEPT
reason: >-
Reactome explicitly places the ACOX2-catalyzed THCA-CoA dehydrogenation in the
peroxisomal matrix. This is the accurate, specific compartment for the soluble
PTS1-targeted enzyme.
supported_by:
- reference_id: Reactome:R-HSA-192335
supporting_text: This dehydrogenation reaction occurs in the peroxisomal matrix.
- term:
id: GO:0005782
label: peroxisomal matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-193369
qualifier: located_in
review:
summary: >-
Peroxisomal matrix localization from Reactome, tied to the curated reaction in which
ACOX2 dehydrogenates 25(S) DHCA-CoA. Accurate compartment for this soluble matrix enzyme.
action: ACCEPT
reason: >-
Reactome places the ACOX2-catalyzed DHCA-CoA dehydrogenation in the peroxisomal matrix,
consistent with the enzyme's soluble matrix localization. Accurate, specific compartment.
supported_by:
- reference_id: Reactome:R-HSA-193369
supporting_text: 25(S) DHCA-CoA is dehydrogenated to 25(S) 3alpha,7alpha-dihydroxy-5beta-cholest-24-enoyl-CoA
- term:
id: GO:0005782
label: peroxisomal matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-389889
qualifier: located_in
review:
summary: >-
Peroxisomal matrix localization from Reactome, tied to the curated reaction in which
ACOX2:FAD oxidizes (2S)-pristanoyl-CoA. Accurate compartment for this soluble matrix
enzyme.
action: ACCEPT
reason: >-
Reactome places the ACOX2-catalyzed pristanoyl-CoA oxidation in the peroxisomal matrix,
consistent with the enzyme's soluble matrix localization. Accurate, specific compartment.
supported_by:
- reference_id: Reactome:R-HSA-389889
supporting_text: >-
monomeric peroxisomal ACOX2 (bound to FAD
cofactor) catalyzes the reaction of (2S)-pristanoyl-CoA
- term:
id: GO:0005782
label: peroxisomal matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9033235
qualifier: located_in
review:
summary: >-
Peroxisomal matrix localization from Reactome, from the peroxisomal-import reaction in
which PEX5 cargo (including ACOX2) is translocated into the matrix. Accurate destination
compartment.
action: ACCEPT
reason: >-
The reaction describes cargo translocation into the peroxisomal matrix, which is ACOX2's
functional destination. Consistent with the other matrix annotations and experimental
data.
supported_by:
- reference_id: Reactome:R-HSA-9033235
supporting_text: Cargo of PEX5S,L translocates from the cytosol to the peroxisomal matrix
- term:
id: GO:0005777
label: peroxisome
evidence_type: IDA
original_reference_id: PMID:8943006
qualifier: located_in
review:
summary: >-
Direct experimental peroxisomal localization: the human branched-chain acyl-CoA oxidase
carries a C-terminal SKL PTS1 signal and was shown to be peroxisomal (and absent from
Zellweger livers by immunoblot/immunocytochemistry). Core localization.
action: ACCEPT
reason: >-
PMID:8943006 provides direct evidence for peroxisomal localization (SKL PTS1; absence in
Zellweger patients, a peroxisome biogenesis disorder). Strong support for the peroxisome
location.
supported_by:
- reference_id: PMID:8943006
supporting_text: >-
The C-terminal tripeptide of the protein is SKL, a
known peroxisome targeting signal.
- term:
id: GO:0005777
label: peroxisome
evidence_type: IDA
original_reference_id: PMID:2079609
qualifier: located_in
review:
summary: >-
Peroxisomal localization inferred from human liver enzymology establishing a separate
peroxisomal trihydroxycoprostanoyl-CoA oxidase (ACOX2), distinct from palmitoyl-CoA
oxidase, catalyzing the first step of peroxisomal beta-oxidation.
action: ACCEPT
reason: >-
PMID:2079609 demonstrates a distinct peroxisomal trihydroxycoprostanoyl-CoA oxidase in
human liver (i.e. ACOX2), supporting its peroxisomal localization. Consistent with all
other localization evidence.
supported_by:
- reference_id: PMID:2079609
supporting_text: >-
Fatty acyl-CoAs as well as the CoA esters of the bile acid intermediates di- and
trihydroxycoprostanic acids are beta-oxidized in peroxisomes.
core_functions:
- description: >-
Peroxisomal branched-chain acyl-CoA oxidase (EC 1.3.3.6): FAD-dependent oxidase that
catalyzes the first, O2-dependent dehydrogenation step of peroxisomal beta-oxidation,
introducing a trans-2,3 double bond into the acyl-CoA and producing H2O2.
molecular_function:
id: GO:0003997
label: acyl-CoA oxidase activity
directly_involved_in:
- id: GO:0006635
label: fatty acid beta-oxidation
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'Reaction=a 2,3-saturated acyl-CoA + O2 = a (2E)-enoyl-CoA + H2O2;'
locations:
- id: GO:0005782
label: peroxisomal matrix
- description: >-
Initiates side-chain shortening of C27 bile-acid intermediates by oxidizing
(25S)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA (THCA-CoA) and DHCA-CoA,
contributing to peroxisomal synthesis of the mature C24 bile acids; loss of this activity
causes ACOX2 deficiency (CBAS6) with C27 intermediate accumulation.
molecular_function:
id: GO:0033791
label: 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity
directly_involved_in:
- id: GO:0006699
label: bile acid biosynthetic process
supported_by:
- reference_id: PMID:27884763
supporting_text: >-
Acyl-CoA oxidase (ACOX2) is involved in the shortening of C27
cholesterol derivatives to generate C24 bile acids.
locations:
- id: GO:0005782
label: peroxisomal matrix
- description: >-
Oxidizes 2-methyl-branched-chain fatty acyl-CoA esters such as (2S)-pristanoyl-CoA
(stereospecific for (2S)-methyl isomers), functioning in peroxisomal beta-oxidation of
branched-chain fatty acids with redundancy to ACOX3.
molecular_function:
id: GO:0016402
label: pristanoyl-CoA oxidase activity
directly_involved_in:
- id: GO:0006635
label: fatty acid beta-oxidation
supported_by:
- reference_id: file:human/ACOX2/ACOX2-uniprot.txt
supporting_text: 'Reaction=(2S)-pristanoyl-CoA + O2 = (2E)-pristenoyl-CoA + H2O2;'
locations:
- id: GO:0005782
label: peroxisomal matrix
proposed_new_terms: []
suggested_questions:
- question: >-
What is the relative in vivo contribution of ACOX2 vs ACOX3 to pristanoyl-CoA /
branched-chain fatty acid beta-oxidation in human tissues, given the reported redundancy?
- question: >-
Do the STRN3 and DYNLT1 interactions reported in high-throughput screens have any
physiological relevance to ACOX2 peroxisomal function or regulation?
suggested_experiments:
- description: >-
Quantitative enzyme kinetics of purified human ACOX2 on THCA-CoA, DHCA-CoA,
(2S)-pristanoyl-CoA, and straight-chain acyl-CoAs (C10, C16) to define physiological
substrate preference and confirm the low-efficiency straight-chain activity.
- description: >-
Tissue-specific metabolic profiling (bile-acid intermediates, branched-chain fatty acids)
in ACOX2-knockout vs ACOX3-knockout models to disentangle the overlapping branched-chain
fatty acid roles.
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000116
title: Automatic Gene Ontology annotation based on Rhea mapping
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:2079609
title: Separate peroxisomal oxidases for fatty acyl-CoAs and trihydroxycoprostanoyl-CoA
in human liver.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Establishes a distinct peroxisomal trihydroxycoprostanoyl-CoA oxidase in human liver
(i.e. ACOX2), separate from palmitoyl-CoA oxidase; supports peroxisomal localization and
the bile-acid-intermediate role. Cited quotes verified verbatim against the cached
abstract.
- id: PMID:27884763
title: 'ACOX2 deficiency: An inborn error of bile acid synthesis identified in an
adolescent with persistent hypertransaminasemia.'
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Primary experimental (IDA/IMP) source: patient R225W mutation causes accumulation of C27
intermediates and loss of C24 bile acids; WT (not mutant) ACOX2 enhances THCA to cholic
acid conversion; peroxisomal localization confirmed by immunofluorescence. Directly
supports the bile-acid biosynthesis and THCA-CoA oxidase core functions.
- id: PMID:28514442
title: Architecture of the human interactome defines protein communities and disease
networks.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
High-throughput (BioPlex) interactome study yielding a bare "protein binding"
(ACOX2-STRN3) annotation. Correctly cited but functionally uninformative for ACOX2;
marked as over-annotation.
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
HuRI binary (Y2H) interactome map yielding a bare "protein binding" (ACOX2-DYNLT1)
annotation. Correctly cited but functionally uninformative for ACOX2; marked as
over-annotation.
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Proteome-scale (BioPlex 3.0) interactome study yielding a bare "protein binding"
(ACOX2-STRN3) annotation. Correctly cited but functionally uninformative for ACOX2;
marked as over-annotation.
- id: PMID:8943006
title: 'Molecular characterization of the human peroxisomal branched-chain acyl-CoA
oxidase: cDNA cloning, chromosomal assignment, tissue distribution, and evidence
for the absence of the protein in Zellweger syndrome.'
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Original molecular characterization of human ACOX2 (hBRCACox): 681-aa protein, C-terminal
SKL PTS1, peroxisomal (absent in Zellweger livers), human homolog of rat THCC oxidase.
Supports peroxisomal localization and identity. Quotes verified verbatim.
- id: file:human/ACOX2/ACOX2-uniprot.txt
title: UniProtKB entry Q99424 (ACOX2_HUMAN), Peroxisomal acyl-coenzyme A oxidase 2
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Curated UniProt record. Source of FUNCTION, catalytic activities (EC 1.3.3.6; Rhea
reactions for THCA-CoA, pristanoyl-CoA, decanoyl/hexadecanoyl-CoA), FAD cofactor,
homodimer subunit, peroxisome subcellular location, and CBAS6 disease association.
- id: Reactome:R-HSA-192335
title: 25(S) THCA-CoA is dehydrogenated to 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA
(THCA-CoA)
findings: []
- id: Reactome:R-HSA-193369
title: 25(S) DHCA-CoA is dehydrogenated to 25(S) 3alpha,7alpha-dihydroxy-5beta-cholest-24-enoyl-CoA
findings: []
- id: Reactome:R-HSA-389889
title: ACOX2:FAD, ACOXL:FAD oxidise (2S)-pristanoyl-CoA to trans-2,3-dehydropristanoyl-CoA
findings: []
- id: Reactome:R-HSA-9033235
title: Cargo of PEX5S,L translocates from the cytosol to the peroxisomal matrix
findings: []
- id: Reactome:R-HSA-9033236
title: PEX5S,L:Cargo binds PEX13:PEX14:PEX2:PEX10:PEX12 (Docking and Translocation
Module)
findings: []